PPTA Twitter

PlasmaProteins
PlasmaProteins #Plasma goes through a complex manufacturing process known as fractionation where proteins are separated to develop #plasmaprotein therapies. Learn more about the process: bit.ly/2ytTQCI pic.twitter.com/ZYK7nzwrvi
1 day ago.
PlasmaProteins
PlasmaProteins Next month, @PlasmaProteins will hold its annual Fly-In on Capitol Hill! PPTA, its membership, and stakeholders will advocate for patient protections & the importance of prohibitions on lifetime and annual caps for people who need #plasmaprotein therapies. bit.ly/2FRKqnR
2 days ago.

Restrictive Coverage Policies and Patient Access

 Please read this timely article by Mark Ballow, M.D. published in Healthcare Payer News.  Dr. Ballow addresses restrictive coverage policies that have a negative impact on patient access and patient care; particularly focusing on patients with primary immunodeficiency diseases.

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100